PubRank

Randall K Ten Haken

Author PubWeight™ 93.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 2010 4.33
2 Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 2002 3.64
3 Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys 2006 3.40
4 High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 2005 3.32
5 Radiation dose-volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys 2010 2.69
6 Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. Int J Radiat Oncol Biol Phys 2003 2.41
7 Radiation-associated liver injury. Int J Radiat Oncol Biol Phys 2010 2.39
8 Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys 2010 2.32
9 Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J Clin Oncol 2005 2.20
10 Partial volume tolerance of the liver to radiation. Semin Radiat Oncol 2005 1.85
11 Radiation-associated kidney injury. Int J Radiat Oncol Biol Phys 2010 1.74
12 Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing. Int J Radiat Oncol Biol Phys 2009 1.64
13 A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer. J Clin Oncol 2007 1.55
14 Retrospective analysis of prostate cancer patients with implanted gold markers using off-line and adaptive therapy protocols. Int J Radiat Oncol Biol Phys 2005 1.55
15 The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy. Int J Radiat Oncol Biol Phys 2006 1.52
16 Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys 2005 1.49
17 Improving normal tissue complication probability models: the need to adopt a "data-pooling" culture. Int J Radiat Oncol Biol Phys 2010 1.44
18 CT-based definition of thoracic lymph node stations: an atlas from the University of Michigan. Int J Radiat Oncol Biol Phys 2005 1.38
19 Dose reconstruction in deforming lung anatomy: dose grid size effects and clinical implications. Med Phys 2005 1.36
20 Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates. Int J Radiat Oncol Biol Phys 2011 1.33
21 Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer. World J Surg 2003 1.28
22 Parotid gland function after radiotherapy: the combined michigan and utrecht experience. Int J Radiat Oncol Biol Phys 2010 1.21
23 Methodological issues in radiation dose-volume outcome analyses: summary of a joint AAPM/NIH workshop. Med Phys 2002 1.20
24 Guest editor's introduction to QUANTEC: a users guide. Int J Radiat Oncol Biol Phys 2010 1.20
25 Association of 11C-methionine PET uptake with site of failure after concurrent temozolomide and radiation for primary glioblastoma multiforme. Int J Radiat Oncol Biol Phys 2008 1.14
26 How extensive of a 4D dataset is needed to estimate cumulative dose distribution plan evaluation metrics in conformal lung therapy? Med Phys 2007 1.13
27 Use of principal component analysis to evaluate the partial organ tolerance of normal tissues to radiation. Int J Radiat Oncol Biol Phys 2005 1.11
28 Physical models and simpler dosimetric descriptors of radiation late toxicity. Semin Radiat Oncol 2007 1.10
29 Liver function after irradiation based on computed tomographic portal vein perfusion imaging. Int J Radiat Oncol Biol Phys 2007 1.08
30 A method for incorporating organ motion due to breathing into 3D dose calculations in the liver: sensitivity to variations in motion. Med Phys 2003 1.08
31 Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer. Radiother Oncol 2005 1.08
32 Imaging for assessment of radiation-induced normal tissue effects. Int J Radiat Oncol Biol Phys 2010 1.07
33 Defining target volumes for non-small cell lung carcinoma. Semin Radiat Oncol 2004 1.06
34 A fluence convolution method to account for respiratory motion in three-dimensional dose calculations of the liver: a Monte Carlo study. Med Phys 2003 1.06
35 A comparison of dose-response models for the parotid gland in a large group of head-and-neck cancer patients. Int J Radiat Oncol Biol Phys 2009 1.05
36 Combining physical and biologic parameters to predict radiation-induced lung toxicity in patients with non-small-cell lung cancer treated with definitive radiation therapy. Int J Radiat Oncol Biol Phys 2012 1.05
37 Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma. Clin Cancer Res 2011 1.05
38 Synchronized dynamic dose reconstruction. Med Phys 2007 1.03
39 Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small-cell lung cancer: is low incidence of regional failure due to incidental nodal irradiation? Int J Radiat Oncol Biol Phys 2005 1.01
40 Alterations in normal liver doses due to organ motion. Int J Radiat Oncol Biol Phys 2003 1.00
41 Prediction of liver function by using magnetic resonance-based portal venous perfusion imaging. Int J Radiat Oncol Biol Phys 2012 0.99
42 A practical approach for quantitative estimates of voxel-by-voxel liver perfusion using DCE imaging and a compartmental model. Med Phys 2006 0.98
43 Evaluating changes in tumor volume using magnetic resonance imaging during the course of radiotherapy treatment of high-grade gliomas: Implications for conformal dose-escalation studies. Int J Radiat Oncol Biol Phys 2005 0.95
44 Multiple fields may offer better esophagus sparing without increased probability of lung toxicity in optimized IMRT of lung tumors. Int J Radiat Oncol Biol Phys 2006 0.95
45 Metabolic Tumor Volume on PET Reduced More than Gross Tumor Volume on CT during Radiotherapy in Patients with Non-Small Cell Lung Cancer Treated with 3DCRT or SBRT. J Radiat Oncol 2013 0.93
46 Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer. Lung Cancer 2004 0.92
47 Daily prostate targeting using implanted radiopaque markers. Int J Radiat Oncol Biol Phys 2002 0.91
48 Benefit of using biologic parameters (EUD and NTCP) in IMRT optimization for treatment of intrahepatic tumors. Int J Radiat Oncol Biol Phys 2005 0.91
49 Time to metabolic atrophy after permanent prostate seed implantation based on magnetic resonance spectroscopic imaging. Int J Radiat Oncol Biol Phys 2004 0.91
50 Semiquantification and classification of local pulmonary function by V/Q single photon emission computed tomography in patients with non-small cell lung cancer: potential indication for radiotherapy planning. J Thorac Oncol 2011 0.90
51 Accounting for center-of-mass target motion using convolution methods in Monte Carlo-based dose calculations of the lung. Med Phys 2004 0.89
52 Changes in global function and regional ventilation and perfusion on SPECT during the course of radiotherapy in patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2011 0.89
53 Lhermitte sign after chemo-IMRT of head-and-neck cancer: incidence, doses, and potential mechanisms. Int J Radiat Oncol Biol Phys 2012 0.88
54 Evaluating the influence of setup uncertainties on treatment planning for focal liver tumors. Int J Radiat Oncol Biol Phys 2005 0.87
55 Evaluating the relationships between rectal normal tissue complication probability and the portion of seminal vesicles included in the clinical target volume in intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2009 0.86
56 FusionArc optimization: a hybrid volumetric modulated arc therapy (VMAT) and intensity modulated radiation therapy (IMRT) planning strategy. Med Phys 2013 0.85
57 Functional and molecular image guidance in radiotherapy treatment planning optimization. Semin Radiat Oncol 2011 0.85
58 Utility of normal tissue-to-tumor α/β ratio when evaluating isodoses of isoeffective radiation therapy treatment plans. Int J Radiat Oncol Biol Phys 2012 0.84
59 Poor baseline pulmonary function may not increase the risk of radiation-induced lung toxicity. Int J Radiat Oncol Biol Phys 2012 0.82
60 Predicting outcome of patients with high-grade gliomas after radiotherapy using quantitative analysis of T1-weighted magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2007 0.82
61 The impact of breathing motion versus heterogeneity effects in lung cancer treatment planning. Med Phys 2007 0.81
62 The influence of beam model differences in the comparison of dose calculation algorithms for lung cancer treatment planning. Phys Med Biol 2005 0.81
63 Ideal spatial radiotherapy dose distributions subject to positional uncertainties. Phys Med Biol 2006 0.81
64 Response-driven imaging biomarkers for predicting radiation necrosis of the brain. Phys Med Biol 2014 0.80
65 Effect of normal lung definition on lung dosimetry and lung toxicity prediction in radiation therapy treatment planning. Int J Radiat Oncol Biol Phys 2013 0.80
66 A Bayesian mixture model relating dose to critical organs and functional complication in 3D conformal radiation therapy. Biostatistics 2005 0.80
67 Esophagus sparing with IMRT in lung tumor irradiation: an EUD-based optimization technique. Int J Radiat Oncol Biol Phys 2005 0.79
68 Predictive models for regional hepatic function based on 99mTc-IDA SPECT and local radiation dose for physiologic adaptive radiation therapy. Int J Radiat Oncol Biol Phys 2013 0.79
69 Dosimetric analysis of radiation-induced gastric bleeding. Int J Radiat Oncol Biol Phys 2012 0.78
70 An application of Bayesian statistical methods to adaptive radiotherapy. Phys Med Biol 2005 0.78
71 Monte Carlo-based lung cancer treatment planning incorporating PET-defined target volumes. J Appl Clin Med Phys 2005 0.78
72 Effect of daily localization and correction on the setup uncertainty: dependences on the measurement uncertainty, re-positioning uncertainty and action level. Phys Med Biol 2007 0.77
73 Body mass index predicts the incidence of radiation pneumonitis in breast cancer patients. Cancer J 2005 0.76
74 Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma: in regards to Xu et al. (Int J Radiat Oncol Biol Phys 2006;65:189-195). Int J Radiat Oncol Biol Phys 2006 0.75
75 Optimizing global liver function in radiation therapy treatment planning. Phys Med Biol 2016 0.75
76 Designing targets for elective nodal irradiation in lung cancer radiotherapy: a planning study. Int J Radiat Oncol Biol Phys 2008 0.75
77 Radiogenomics and radiotherapy response modeling. Phys Med Biol 2017 0.75
78 Dosimetric implications of residual seminal vesicle motion in fiducial-guided intensity-modulated radiotherapy for prostate cancer. Med Dosim 2011 0.75
79 Reporting and analyzing statistical uncertainties in Monte Carlo-based treatment planning. Int J Radiat Oncol Biol Phys 2006 0.75